Genetic interactions between Pten and p53 in radiation-induced lymphoma development

被引:41
作者
Mao, JH
Wu, D
Perez-Losada, J
Nagase, H
DelRosario, R
Balmain, A
机构
[1] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
[2] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA
关键词
Pten; p53; loss of heterozygosity; intragenic deletion; radiation induced lymphoma;
D O I
10.1038/sj.onc.1207083
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genetic analysis of radiation-induced lymphomas from p53 heterozygous or null mice has revealed a high frequency of genetic alterations on mouse chromosome 19. Detailed microsatellite analysis of chromosome 19 deletions identified three independent regions of loss of heterozygosity, one of which was refined to a 0.3 Mb interval that contained the Pten tumor suppressor gene. More than 50% of radiation-induced tumors from p53+/- and p53-/- mice showed heterozygous loss of one Pten allele. In most cases, the remaining allele was wild type and expressed, suggesting that Pten is a haploinsufficient tumor suppressor gene for mouse lymphoma development. This conclusion was supported by the detection of specific intragenic deletions in Pten in tumors that retained one wild-type allele. Pten heterozygous mice were just as sensitive as p53+/- mice to induction of tumors by radiation, and surprisingly, the double p53+/-Pten+/- mice were equivalent to p53 null mice in radiation sensitivity. Despite the fact that Pten appears to be a haploinsufficient tumor suppressor gene, most tumors from both the single and double heterozygous mice had lost the remaining wild-type allele. The mechanism of loss in all cases involved the complete chromosome, suggesting that it is driven by other tumor suppressor genes on this chromosome. This sensitized screen therefore identified complementary roles for Pten and p53 pathways in suppression of tumor development induced by radiation exposure.
引用
收藏
页码:8379 / 8385
页数:7
相关论文
共 33 条
[1]   The p53 network [J].
Agarwal, ML ;
Taylor, WR ;
Chernov, MV ;
Chernova, OB ;
Stark, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :1-4
[2]   Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity [J].
Ali, IU ;
Schriml, LM ;
Dean, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (22) :1922-1932
[3]  
Butler MP, 1999, GENE CHROMOSOME CANC, V24, P322, DOI 10.1002/(SICI)1098-2264(199904)24:4<322::AID-GCC5>3.0.CO
[4]  
2-9
[5]   Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays [J].
Cai, WW ;
Mao, JH ;
Chow, CW ;
Damani, S ;
Balmain, A ;
Bradley, A .
NATURE BIOTECHNOLOGY, 2002, 20 (04) :393-396
[6]   Checkpoints: How to activate p53 [J].
Caspari, T .
CURRENT BIOLOGY, 2000, 10 (08) :R315-R317
[7]   PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies [J].
Dahia, PLM ;
Aguiar, RCT ;
Alberta, J ;
Kum, JB ;
Caron, S ;
Sill, H ;
Marsh, DJ ;
Ritz, J ;
Freedman, A ;
Stiles, C ;
Eng, C .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :185-193
[8]   Pten is essential for embryonic development and tumour suppression [J].
Di Cristofano, A ;
Pesce, B ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE GENETICS, 1998, 19 (04) :348-355
[9]   Regulation of p53 downstream genes [J].
El-Deiry, WS .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) :345-357
[10]   The murine gene p27Kip1 is haplo-insufficient for tumour suppression [J].
Fero, ML ;
Randel, E ;
Gurley, KE ;
Roberts, JM ;
Kemp, CJ .
NATURE, 1998, 396 (6707) :177-180